Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia
Published Online: 2023-04-18
Journal: Nature CommunicationsLoading...
Authors: Alex Kotak•Anna Maria Fink•Barbara Eichhorst•Brenda Chyla•Can Zhang•Christian P. Pallasch•Christof Schneider•Eugen Tausch•Hyun Yong Jin•Joseph N. Paulson•Karl-Anton Kreuzer•Kirsten Fischer•Lukas P. Frenzel•Martin Peifer•Matthias Ritgen•Michael Hallek•Othman Al-Sawaf•Sandhya Balasubramanian•Sandra Robrecht•Stephan Stilgenbauer•Yanwen Jiang•Yi Meng Chang•Yoonha Choi
